Crossmark

Synthetic strategy towards novel composite based on substituted pyrido[2,1-b][1,3,4]oxadiazine-dialdehyde chitosan conjugate with antimicrobial and anticancer activities

Crossref DOI link: https://doi.org/10.1186/s13065-023-01005-1

Published Online: 2023-07-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mohamed-Ezzat, Reham A.

Hashem, Amr H.

Dacrory, Sawsan
Funding

Funding for this research was provided by:

Al-Azhar University
License Information

Text and Data Mining valid from 2023-07-26

Version of Record valid from 2023-07-26
More Information

Article History

Received: 12 February 2023

Accepted: 14 July 2023

First Online: 26 July 2023

Declarations

:

: Not applicable.

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

: The author declare that there is no conflict to interest.

Document is current

Any future updates will be listed below